Elliot Gershon to Cognition
This is a "connection" page, showing publications Elliot Gershon has written about Cognition.
Connection Strength
0.705
-
Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophr Bull. 2021 07 08; 47(4):1058-1067.
Score: 0.138
-
Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum. Am J Psychiatry. 2019 07 01; 176(7):564-572.
Score: 0.119
-
Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res. 2017 12; 190:129-135.
Score: 0.103
-
Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1. Schizophr Res. 2023 10; 260:143-151.
Score: 0.040
-
Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosis. Brain Behav Immun. 2023 11; 114:3-15.
Score: 0.040
-
Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum. Schizophr Res. 2022 10; 248:79-88.
Score: 0.037
-
A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits. Neuropsychopharmacology. 2022 11; 47(12):2024-2032.
Score: 0.036
-
Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. Am J Psychiatry. 2021 10 01; 178(10):952-964.
Score: 0.035
-
Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry. 2021 07; 26(7):3430-3443.
Score: 0.033
-
Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophr Res. 2020 09; 223:236-241.
Score: 0.032
-
Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophr Res. 2020 09; 223:148-157.
Score: 0.032
-
The association between lithium use and neurocognitive performance in patients with bipolar disorder. Neuropsychopharmacology. 2020 09; 45(10):1743-1749.
Score: 0.032
-
Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018 04 12; 8(1):78.
Score: 0.028